Lv4
530 积分 2024-08-17 加入
Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases
1个月前
已完结
Macrophages restrict tumor immune infiltration by controlling collagen topography
1个月前
已完结
Microbiome modulation in cancer immunotherapy
1个月前
已完结
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth
1个月前
已完结
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
1个月前
已完结
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
1个月前
已完结
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
1个月前
已完结
The influence of bone metastasis in immunotherapy response
1个月前
已完结
Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram
1个月前
已完结
Efficacy and safety of neoadjuvant immunotherapy in resectable nonsmall cell lung cancer: A meta-analysis
1个月前
已完结
皖公网安备34019202002308
